Optical biosensing platform utilizing nanocrystalline zinc oxide
First Claim
1. An optical biosensing platform for the real-time detection of the occurrence of a binding event, the optical biosensing platform comprising:
- a nanocrystalline zinc oxide (nano-ZnO) substrate having a surface and being capable of emitting photoluminescence, said photoluminescence comprising an inherent photoluminescence signal consisting of two emission peaks, a first peak being within an ultraviolet (UV) region of an electromagnetic spectrum, and a second peak being within a visible region of the spectrum; and
a surface modifier being capable of binding to a biomolecule, said modifier formed integral with at least a portion of the surface of the nano-ZnO substrate, said surface modifier being chosen for attaching a specific receptor, said receptor for allowing the binding of a particular target biomolecule;
wherein when the surface modifier binds with a said biomolecule, a change is induced in the emission of the inherent photoluminescent properties of the nano-ZnO substrate, said change occurring in at least one of the group consisting of emission intensities, emission maxima shifts and peak proportionalities of the inherent photoluminescent properties of the nano-ZnO substrate thereby enabling the detection of a binding event.
2 Assignments
0 Petitions
Accused Products
Abstract
An optical biosensing platform for the real-time detection of the occurrence of a binding event, the optical biosensing platform comprising a nanocrystalline zinc oxide (nano-ZnO) substrate having a surface and being capable of emitting photoluminescence and a surface modifier formed integral with at least a portion of the surface of the nano-ZnO substrate, wherein the surface modifier is capable of binding to a biomolecule and wherein when the surface modifier binds with a biomolecule, a change is induced in the emitted photoluminescent properties of the nano-ZnO substrate, thereby enabling the detection of a binding event.
-
Citations
7 Claims
-
1. An optical biosensing platform for the real-time detection of the occurrence of a binding event, the optical biosensing platform comprising:
-
a nanocrystalline zinc oxide (nano-ZnO) substrate having a surface and being capable of emitting photoluminescence, said photoluminescence comprising an inherent photoluminescence signal consisting of two emission peaks, a first peak being within an ultraviolet (UV) region of an electromagnetic spectrum, and a second peak being within a visible region of the spectrum; and a surface modifier being capable of binding to a biomolecule, said modifier formed integral with at least a portion of the surface of the nano-ZnO substrate, said surface modifier being chosen for attaching a specific receptor, said receptor for allowing the binding of a particular target biomolecule; wherein when the surface modifier binds with a said biomolecule, a change is induced in the emission of the inherent photoluminescent properties of the nano-ZnO substrate, said change occurring in at least one of the group consisting of emission intensities, emission maxima shifts and peak proportionalities of the inherent photoluminescent properties of the nano-ZnO substrate thereby enabling the detection of a binding event. - View Dependent Claims (2, 3, 4)
-
-
5. A method for detecting the occurrence of a binding event, the method comprising:
-
providing an optical biosensing platform comprising; a nanocrystalline zinc oxide (nano-ZnO) substrate having a surface and being capable of emitting photoluminescence, said photoluminescence comprising an inherent photoluminescence signal consisting of two emission peaks, a first peak being within an ultraviolet (UV) region of an electromagnetic spectrum, and a second peak being within a visible region of the spectrum; and a surface modifier being capable of binding to a specific biomolecule, said modifier formed integral with at least a portion of the surface of the nano-ZnO substrate, said surface modifier being chosen for attaching a specific receptor, said receptor for allowing the binding of a particular target biomolecule, wherein when the surface modifier binds with a said biomolecule, a change is induced in the emission of the inherent photoluminescent properties of the nano-ZnO substrate, said change occurring in at least one of the group consisting of emission intensities, emission maxima shifts and peak proportionalities of the inherent photoluminescent properties of the nano-ZnO substrate; providing a sample which potentially contains at least one biomolecule capable of binding with the surface modifier; and observing the nano-ZnO substrate to determine whether a said change in said inherent photoluminescent properties of the nano-ZnO substrate has been induced, thereby enabling the detection of a binding event.
-
-
6. A method for manufacturing an optical biosensing platform for the real-time detection of the occurrence of a binding event, the method comprising:
-
providing a nanocrystalline zinc oxide (nano-ZnO) substrate having a surface and being capable of emitting photoluminescence; and integrating a surface modifier with at least a portion of the surface of the nano-ZnO substrate, wherein the surface modifier is capable of binding to a specific biomolecule, and wherein said surface modifier comprises a silane cross-linking agent, said integrating comprising; attaching the agent to the nano-ZnO surface for introducing a chemical reactive group for allowing biofunctionalization; verifying a presence of the agent; confirming a concentration of Si on the surface; washing the surface for removing any noncovalently attached agent; and verifying stability of the chemical reactive group for maintaining functionality for forming a biomolecule complex. - View Dependent Claims (7)
-
Specification